Marie M Hand, MD
Internal Medicine · Wichita
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Holy Family Medical Inc · Amberwell Atchison Association
Looking this up.
Hospitals listed: 177117 · 178104 · 178105 · Amberwell Atchison Association · Ascension Via Christi Hospitals Wichita, Inc. · Rock Regional Hospital, LLC. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hand’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Amberwell Atchison AssociationAtchison, KSCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPatients rate it 4 of 5 · 71% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Ascension Via Christi Hospitals Wichita, Inc.Wichita, KSAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ascension Health, which runs 120 hospitals in 13 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.194, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.374, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.248, Oct 2024 – Sep 2025
- Rock Regional Hospital, LLCDerby, KSAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 4 of 5 · 92% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Amberwell Atchison Association
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 281 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 70 cases | None | Apr 2023 – Mar 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.8 · 76 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 68 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 27 cases | None | Jul 2023 – Jun 2025 |
What patients said (155 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 86% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 86% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 67% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Ascension Via Christi Hospitals Wichita, Inc.
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.194 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.248 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.78) · 1,726 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.65 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 194.99 (155.44 to 234.55) · 170 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 280 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 627 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 452 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 4,183 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.07 to 0.45) · 9,772 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.47) · 10,223 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.08 (0.38 to 3.77) · 3,062 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.5) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.77 (0.51 to 3.03) · 2,819 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.8 (6.16 to 15.44) · 1,234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.47 to 9.39) · 1,319 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.48 (0.08 to 2.89) · 548 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 0.88) · 8,317 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 61 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.787 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.648 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 559 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -10 · 308 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 16.2 · 499 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.3 · 694 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.4 · 840 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 173 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.7 to 19.1) · 289 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 142 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Rock Regional Hospital, LLC
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 57 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.45 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 285 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 683 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (0.8 to 6.02) · 138 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.8 (0 to 18.66) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.12 (0.83 to 9.41) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.55 (0 to 1.81) · 426 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -25.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 145 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 38 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10.1 to 17.9) · 594 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 142 cases | No different | Jan 2024 – Dec 2024 |
What patients said (161 patients answered, 38% of those asked)
| Cleanliness | 3 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 87% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 83% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 94% |
| Patients who gave a rating of "9" or "10" (high) | 83% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 92% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$77,710
Medicare paid this office $77,710 for 190 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 157 | $28,355 | $78 |
| Long return visit (40+ min) | 83 | $15,882 | $125 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 99 | $11,848 | $120 |
| Short return visit (20+ min) | 63 | $5,436 | $63 |
| Insertion of needle into vein for collection of blood sample | 154 | $2,509 | $9 |
See all 14 services
| Return visit (30+ min) | 157 | $28,355 | $78 |
| Long return visit (40+ min) | 83 | $15,882 | $125 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 99 | $11,848 | $120 |
| Short return visit (20+ min) | 63 | $5,436 | $63 |
| Insertion of needle into vein for collection of blood sample | 154 | $2,509 | $9 |
| Short return visit | 45 | $1,714 | $34 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 67 | $1,283 | $15 |
| Influenza vaccine, trivalent derived from cell cultures | 39 | $1,147 | $29 |
| Administration of influenza virus vaccine | 34 | $1,018 | $30 |
| Injection of drug or substance under skin or into muscle | 12 | $628 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 36 | $416 | $10 |
| Annual depression screening, 5 to 15 minutes | 12 | $206 | $17 |
| Automated urinalysis test | 24 | $77 | $2 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 12 | $61 | None |
Who their Medicare patients are
190 Original Medicare patients in 2024. Average age 79 · 85 and older 30% · Women 58% · Health risk score 1.19. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 34% · Diabetes 29% · Atrial fibrillation 26% · Depression 26% · Chronic kidney disease 24% · Cancer 19% · Heart failure 17% · COPD 15% · Stroke 11% · Dementia 10%.
The office billed $183,578, Medicare allowed $102,877 and paid $77,710; for 1,453 services of 34 kinds; $1,207 of it was for drugs given in the office and $76,502 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 190 | 1,453 | 79 | 1.19 | $183,578 | $77,710 |
| 2023 | 234 | 2,132 | 79 | 1.24 | $196,745 | $97,060 |
| 2022 | 246 | 1,753 | 79 | 1.16 | $168,141 | $90,861 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Return visit (30+ min) | 203 | $50,859 | $79 |
| Long return visit (40+ min) | 75 | $13,292 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $10,077 | $120 |
| Insertion of needle into vein for collection of blood sample | 210 | $5,219 | $8 |
| Transitional care management services for problem of high complexity | 13 | $3,001 | $188 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 54 | $1,808 | $33 |
| Short return visit (20+ min) | 28 | $1,735 | $54 |
| New patient visit (45+ min) | 18 | $1,579 | $88 |
| Administration of influenza virus vaccine | 53 | $1,508 | $28 |
| Annual depression screening, 5 to 15 minutes | 65 | $1,104 | $17 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $943 | $35 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 16 | $649 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 44 | $570 | $10 |
| Detection test by immunoassay with direct visual observation for influenza virus | 16 | $373 | $16 |
| Injection of drug or substance under skin or into muscle | 13 | $303 | $9 |
| Automated urinalysis test | 46 | $158 | $2 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 17 | $102 | None |
2022: 17 services
| Return visit (30+ min) | 206 | $48,415 | $90 |
| Long return visit (40+ min) | 72 | $11,542 | $128 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $10,173 | $123 |
| New patient visit (45+ min) | 27 | $2,976 | $110 |
| Transitional care management services for problem of high complexity | 12 | $2,914 | $208 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 71 | $2,246 | $32 |
| Short return visit (20+ min) | 31 | $2,236 | $66 |
| Administration of influenza virus vaccine | 67 | $1,837 | $27 |
| Insertion of needle into vein for collection of blood sample | 212 | $1,266 | $3 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $944 | $39 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 12 | $528 | $41 |
| Injection of drug or substance under skin or into muscle | 14 | $463 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 41 | $462 | $10 |
| Annual depression screening, 5 to 15 minutes | 26 | $443 | $17 |
| Detection test by immunoassay with direct visual observation for influenza virus | 12 | $325 | $16 |
| Automated urinalysis test | 42 | $130 | $2 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 15 | $94 | None |
Drugs they prescribed that Part D paid
$402,358
Pharmacies billed $402,358 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (331 of 5,340) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 9% of their opioid prescriptions.
4,612 generic and 680 brand-name prescriptions · $402,358 in drug cost · 168 antibiotic prescriptions to 75 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 84 | $70,175 | $835 |
| Mounjaro | 56 | $67,127 | $1,199 |
| Farxiga | 33 | $24,156 | $732 |
| Jardiance | 34 | $20,821 | $612 |
| Ozempic | 11 | $18,821 | $1,711 |
See all 108 drugs
| Eliquis | 84 | $70,175 | $835 |
| Mounjaro | 56 | $67,127 | $1,199 |
| Farxiga | 33 | $24,156 | $732 |
| Jardiance | 34 | $20,821 | $612 |
| Ozempic | 11 | $18,821 | $1,711 |
| Breztri Aerosphere | 16 | $16,413 | $1,026 |
| Rybelsus | 16 | $14,267 | $892 |
| Basaglar Kwikpen U-100 | 17 | $10,231 | $602 |
| Myrbetriq | 11 | $7,635 | $694 |
| Breo Ellipta | 19 | $7,548 | $397 |
| Xarelto | 13 | $6,909 | $531 |
| Buprenorphine | 12 | $5,321 | $443 |
| Novolog Flexpen | 14 | $4,949 | $353 |
| Diclofenac | 18 | $4,075 | $226 |
| Potassium Chloride | 117 | $3,874 | $33 |
| Hydrocodone-Acetaminophen | 93 | $2,459 | $26 |
| Atorvastatin | 353 | $2,222 | $6 |
| Gabapentin | 136 | $2,006 | $15 |
| Omeprazole | 143 | $1,917 | $13 |
| Levothyroxine | 237 | $1,781 | $8 |
| Rivastigmine | 12 | $1,722 | $144 |
| Synthroid | 25 | $1,662 | $66 |
| Pregabalin | 22 | $1,652 | $75 |
| Scopolamine | 11 | $1,453 | $132 |
| Ventolin Hfa | 22 | $1,446 | $66 |
| Tramadol | 104 | $1,407 | $14 |
| Metformin | 100 | $1,001 | $10 |
| Metoprolol | 99 | $938 | $9 |
| Lantus Solostar | 20 | $936 | $47 |
| Amlodipine Besylate | 212 | $907 | $4 |
| Buspirone | 58 | $876 | $15 |
| Ondansetron Odt | 45 | $817 | $18 |
| Tamsulosin | 73 | $811 | $11 |
| Esomeprazole Magnesium | 12 | $800 | $67 |
| Losartan | 126 | $788 | $6 |
| Sucralfate | 20 | $784 | $39 |
| Estradiol | 25 | $699 | $28 |
| Nebivolol | 13 | $668 | $51 |
| Fluticasone Propionate | 43 | $660 | $15 |
| Lisinopril | 121 | $610 | $5 |
| Pantoprazole | 47 | $589 | $13 |
| Rosuvastatin | 40 | $535 | $13 |
| Simvastatin | 63 | $511 | $8 |
| Clopidogrel | 36 | $499 | $14 |
| Metformin Hcl Er | 94 | $499 | $5 |
| Pravastatin | 38 | $496 | $13 |
| Sertraline | 90 | $488 | $5 |
| Albuterol Sulfate Hfa | 23 | $467 | $20 |
| Sumatriptan | 21 | $465 | $22 |
| Acetaminophen-Codeine | 35 | $451 | $13 |
| Olmesartan Medoxomil | 40 | $430 | $11 |
| Glipizide | 28 | $412 | $15 |
| Fluoxetine | 38 | $408 | $11 |
| Bumetanide | 30 | $404 | $13 |
| Oxybutynin Chloride Er | 20 | $397 | $20 |
| Ropinirole | 35 | $388 | $11 |
| Oxycodone-Acetaminophen | 29 | $374 | $13 |
| Cefdinir | 39 | $358 | $9 |
| Carvedilol | 67 | $355 | $5 |
| Hydrochlorothiazide | 119 | $353 | $3 |
| Morphine Sulfate | 22 | $346 | $16 |
| Cyclobenzaprine | 36 | $336 | $9 |
| Trazodone | 80 | $319 | $4 |
| Lisinopril-Hydrochlorothiazide | 38 | $308 | $8 |
| Methadone | 13 | $281 | $22 |
| Lorazepam | 49 | $269 | $5 |
| Bupropion Hcl Sr | 11 | $264 | $24 |
| Furosemide | 68 | $258 | $4 |
| Allopurinol | 33 | $257 | $8 |
| Finasteride | 30 | $253 | $8 |
| Amitriptyline | 15 | $245 | $16 |
| Oxybutynin Chloride | 17 | $219 | $13 |
| Doxycycline Hyclate | 18 | $219 | $12 |
| Donepezil | 36 | $215 | $6 |
| Lamotrigine | 11 | $206 | $19 |
| Ezetimibe | 13 | $203 | $16 |
| Losartan-Hydrochlorothiazide | 36 | $202 | $6 |
| Amoxicillin-Clavulanate Potass | 27 | $201 | $7 |
| Latanoprost | 12 | $199 | $17 |
| Spironolactone | 28 | $191 | $7 |
| Atenolol | 22 | $191 | $9 |
| Escitalopram | 46 | $185 | $4 |
| Mirtazapine | 43 | $185 | $4 |
| Temazepam | 15 | $180 | $12 |
| Duloxetine | 30 | $179 | $6 |
| Citalopram Hbr | 40 | $159 | $4 |
| Azithromycin | 30 | $159 | $5 |
| Prednisone | 37 | $157 | $4 |
| Famotidine | 16 | $149 | $9 |
| Metoprolol | 41 | $146 | $4 |
| Montelukast | 22 | $141 | $6 |
| Klor-Con M20 | 11 | $134 | $12 |
| Venlafaxine Hcl Er | 11 | $126 | $11 |
| Hydroxyzine | 12 | $122 | $10 |
| Telmisartan | 23 | $122 | $5 |
| Zolpidem | 20 | $111 | $6 |
| Chlorthalidone | 16 | $108 | $7 |
| Tizanidine | 19 | $106 | $6 |
| Oxycodone | 19 | $97 | $5 |
| Diltiazem 24hr Er (Cd) | 11 | $91 | $8 |
| Alprazolam | 13 | $60 | $5 |
| Diazepam | 16 | $56 | $4 |
| Fluconazole | 17 | $52 | $3 |
| Bupropion | 12 | $51 | $4 |
| Diphenoxylate-Atropine | 26 | $42 | $2 |
| Baclofen | 18 | $36 | $2 |
| Triamterene-Hydrochlorothiazid | 15 | $14 | $1 |
| Paxlovid | 12 | $0 | $0 |
Year by year
| 2024 | 5,340 | 264 | 6% (331) | 13% | $402,358 |
| 2023 | 5,186 | 259 | 6% (330) | 12% | $409,352 |
| 2022 | 2,607 | 241 | 10% (271) | 12% | $202,790 |
| 2021 | 12 | None | 0% (0) | None | $518 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 109 drugs
| Eliquis | 60 | $57,956 | $966 |
| Jardiance | 29 | $22,986 | $793 |
| Trulicity | 18 | $19,302 | $1,072 |
| Novolog Flexpen | 11 | $17,823 | $1,620 |
| Mounjaro | 15 | $17,532 | $1,169 |
| Breztri Aerosphere | 12 | $14,829 | $1,236 |
| Xarelto | 22 | $14,409 | $655 |
| Farxiga | 16 | $12,811 | $801 |
| Symbicort | 21 | $10,962 | $522 |
| Invokana | 11 | $7,018 | $638 |
| Potassium Chloride | 124 | $5,203 | $42 |
| Hydrocodone-Acetaminophen | 137 | $4,799 | $35 |
| Levothyroxine | 277 | $3,304 | $12 |
| Atorvastatin | 303 | $3,196 | $11 |
| Ventolin Hfa | 31 | $2,893 | $93 |
| Rivastigmine | 12 | $2,687 | $224 |
| Gabapentin | 128 | $2,566 | $20 |
| Basaglar Kwikpen U-100 | 12 | $2,540 | $212 |
| Omeprazole | 152 | $2,379 | $16 |
| Fentanyl | 12 | $2,136 | $178 |
| Duloxetine | 28 | $2,040 | $73 |
| Synthroid | 26 | $1,870 | $72 |
| Metoprolol | 79 | $1,527 | $19 |
| Nano 2nd Gen Pen Needle | 11 | $1,478 | $134 |
| Tamsulosin | 86 | $1,467 | $17 |
| Albuterol Sulfate Hfa | 25 | $1,332 | $53 |
| Telmisartan | 48 | $1,307 | $27 |
| Pantoprazole | 78 | $1,264 | $16 |
| Metformin | 109 | $1,195 | $11 |
| Losartan | 114 | $1,115 | $10 |
| Buspirone | 44 | $945 | $21 |
| Amlodipine Besylate | 180 | $896 | $5 |
| Acetaminophen-Codeine | 25 | $896 | $36 |
| Nebivolol | 11 | $893 | $81 |
| Cephalexin | 24 | $861 | $36 |
| Trazodone | 94 | $840 | $9 |
| Memantine | 11 | $838 | $76 |
| Oxybutynin Chloride Er | 18 | $815 | $45 |
| Tramadol | 86 | $794 | $9 |
| Lisinopril | 133 | $787 | $6 |
| Diclofenac | 19 | $757 | $40 |
| Fluticasone Propionate | 37 | $708 | $19 |
| Rosuvastatin | 36 | $690 | $19 |
| Cefdinir | 34 | $688 | $20 |
| Losartan-Hydrochlorothiazide | 53 | $675 | $13 |
| Simvastatin | 71 | $664 | $9 |
| Oxycodone-Acetaminophen | 28 | $649 | $23 |
| Ondansetron | 21 | $643 | $31 |
| Metoprolol | 67 | $618 | $9 |
| Solifenacin | 12 | $595 | $50 |
| Clopidogrel | 27 | $592 | $22 |
| Carvedilol | 68 | $557 | $8 |
| Bumetanide | 22 | $548 | $25 |
| Sertraline | 80 | $519 | $6 |
| Carbidopa-Levodopa | 17 | $518 | $30 |
| Cyclobenzaprine | 41 | $516 | $13 |
| Digoxin | 15 | $510 | $34 |
| Ezetimibe | 16 | $470 | $29 |
| Ondansetron Odt | 25 | $465 | $19 |
| Nitrofurantoin | 11 | $463 | $42 |
| Metformin Hcl Er | 67 | $448 | $7 |
| Lisinopril-Hydrochlorothiazide | 32 | $439 | $14 |
| Glipizide | 19 | $437 | $23 |
| Methadone | 13 | $432 | $33 |
| Spironolactone | 34 | $430 | $13 |
| Mirtazapine | 41 | $425 | $10 |
| Allopurinol | 28 | $411 | $15 |
| Furosemide | 60 | $400 | $7 |
| Montelukast | 30 | $387 | $13 |
| Amiodarone | 16 | $385 | $24 |
| Fluoxetine | 35 | $382 | $11 |
| Ropinirole | 32 | $366 | $11 |
| Escitalopram | 35 | $365 | $10 |
| Hydrochlorothiazide | 81 | $362 | $4 |
| Lorazepam | 43 | $351 | $8 |
| Estradiol | 23 | $350 | $15 |
| Venlafaxine Hcl Er | 18 | $342 | $19 |
| Diphenoxylate-Atropine | 19 | $336 | $18 |
| Atenolol | 28 | $330 | $12 |
| Donepezil | 29 | $327 | $11 |
| Amoxicillin-Clavulanate Potass | 42 | $288 | $7 |
| Finasteride | 29 | $282 | $10 |
| Azithromycin | 42 | $274 | $7 |
| Doxycycline Monohydrate | 16 | $253 | $16 |
| Tizanidine | 22 | $226 | $10 |
| Alendronate | 20 | $223 | $11 |
| Lansoprazole | 11 | $223 | $20 |
| Warfarin | 42 | $223 | $5 |
| Pravastatin | 30 | $217 | $7 |
| Temazepam | 16 | $211 | $13 |
| Citalopram Hbr | 29 | $205 | $7 |
| Paxlovid (Eua) | 18 | $180 | $10 |
| Glimepiride | 24 | $178 | $7 |
| Diltiazem 24hr Er (Cd) | 17 | $174 | $10 |
| Lamotrigine | 11 | $171 | $16 |
| Fluconazole | 29 | $171 | $6 |
| Chlorthalidone | 15 | $164 | $11 |
| Clonidine | 11 | $152 | $14 |
| Prednisone | 12 | $152 | $13 |
| Terbinafine | 12 | $137 | $11 |
| Oxybutynin Chloride | 11 | $131 | $12 |
| Baclofen | 17 | $111 | $7 |
| Ciprofloxacin | 16 | $97 | $6 |
| Bupropion Hcl Sr | 12 | $68 | $6 |
| Latanoprost | 11 | $58 | $5 |
| Amoxicillin | 16 | $50 | $3 |
| Oxycodone | 13 | $48 | $4 |
| Folic Acid | 21 | $39 | $2 |
| Triamterene-Hydrochlorothiazid | 14 | $4 | $0 |
2022: 68 drugs
| Eliquis | 15 | $16,330 | $1,089 |
| Xarelto | 14 | $8,670 | $619 |
| Jardiance | 12 | $8,344 | $695 |
| Diclofenac | 11 | $4,681 | $426 |
| Symbicort | 11 | $4,363 | $397 |
| Hydrocodone-Acetaminophen | 79 | $2,532 | $32 |
| Potassium Chloride | 57 | $1,732 | $30 |
| Omeprazole | 96 | $1,654 | $17 |
| Gabapentin | 78 | $1,544 | $20 |
| Levothyroxine | 109 | $1,482 | $14 |
| Ventolin Hfa | 16 | $1,353 | $85 |
| Acetaminophen-Codeine | 19 | $1,164 | $61 |
| Atorvastatin | 111 | $1,041 | $9 |
| Tramadol | 97 | $843 | $9 |
| Tamsulosin | 42 | $830 | $20 |
| Buspirone | 30 | $669 | $22 |
| Cyclobenzaprine | 24 | $665 | $28 |
| Albuterol Sulfate Hfa | 13 | $658 | $51 |
| Trazodone | 45 | $633 | $14 |
| Duloxetine | 37 | $594 | $16 |
| Sertraline | 52 | $536 | $10 |
| Oxycodone-Acetaminophen | 23 | $532 | $23 |
| Losartan | 47 | $516 | $11 |
| Clopidogrel | 15 | $467 | $31 |
| Telmisartan | 16 | $464 | $29 |
| Amlodipine Besylate | 63 | $418 | $7 |
| Lisinopril | 64 | $410 | $6 |
| Paxlovid (Eua) | 37 | $384 | $10 |
| Rosuvastatin | 15 | $362 | $24 |
| Doxycycline Monohydrate | 28 | $320 | $11 |
| Cefdinir | 25 | $319 | $13 |
| Metformin | 43 | $313 | $7 |
| Fluticasone Propionate | 15 | $288 | $19 |
| Pantoprazole | 18 | $284 | $16 |
| Furosemide | 42 | $272 | $6 |
| Escitalopram | 14 | $258 | $18 |
| Diphenoxylate-Atropine | 14 | $247 | $18 |
| Spironolactone | 16 | $242 | $15 |
| Lorazepam | 37 | $236 | $6 |
| Carvedilol | 26 | $208 | $8 |
| Hydrochlorothiazide | 31 | $207 | $7 |
| Metoprolol | 17 | $196 | $12 |
| Methadone | 13 | $192 | $15 |
| Lisinopril-Hydrochlorothiazide | 12 | $190 | $16 |
| Alendronate | 13 | $182 | $14 |
| Allopurinol | 15 | $180 | $12 |
| Glimepiride | 11 | $170 | $15 |
| Ropinirole | 14 | $168 | $12 |
| Pravastatin | 15 | $167 | $11 |
| Donepezil | 18 | $164 | $9 |
| Mirtazapine | 19 | $156 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $156 | $14 |
| Amoxicillin-Clavulanate Potass | 17 | $154 | $9 |
| Metoprolol | 31 | $147 | $5 |
| Morphine Sulfate | 11 | $141 | $13 |
| Metformin Hcl Er | 28 | $136 | $5 |
| Estradiol | 12 | $116 | $10 |
| Prednisone | 22 | $113 | $5 |
| Azithromycin | 16 | $111 | $7 |
| Baclofen | 12 | $103 | $9 |
| Meloxicam | 12 | $92 | $8 |
| Citalopram Hbr | 18 | $90 | $5 |
| Simvastatin | 22 | $88 | $4 |
| Oxycodone | 12 | $86 | $7 |
| Temazepam | 11 | $82 | $7 |
| Warfarin | 13 | $59 | $5 |
| Folic Acid | 18 | $52 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $48 | $4 |
Money from drug and device companies
$320 in 2025
| 2025 | 5 | 15 | None | $320 |
| 2024 | 2 | 4 | None | $266 |
| 2023 | 1 | 3 | None | $50 |
| 2022 | 4 | 5 | None | $92 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri | $216 | 5 payments
|
| Astellas Pharma US | Veozah | $42 | 2 payments
|
| Pfizer | Paxlovid | $35 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $14 | 1 payment
|
| Lundbeck | Rexulti | $14 | 1 payment
|
See all 11 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-09 | Airsupra | $14 |
| Astellas Pharma US | Meals · 2025-12-02 | Veozah | $17 |
| Merck Sharp & Dohme | Meals · 2025-11-24 | Gardasil 9 | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-30 | Breztri | $18 |
| Lundbeck | Meals · 2025-10-08 | Rexulti | $14 |
| Astellas Pharma US | Meals · 2025-10-02 | Veozah | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-15 | Breztri | $34 |
| Pfizer | Meals · 2025-04-03 | Paxlovid | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-06 | Breztri | $25 |
| Pfizer | Meals · 2025-02-18 | Paxlovid | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-11 | Breztri | $125 |
See earlier years (2024, 2023, 2022)
2024: $266
| AstraZeneca Pharmaceuticals LP | Farxiga | $251 | 3 payments
|
| Pfizer | Paxlovid | $16 | 1 payment
|
2023: $50
| AstraZeneca Pharmaceuticals LP | Farxiga | $50 | 3 payments
|
2022: $92
| Novo Nordisk | Ozempic | $45 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $15 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $15 | 1 payment
|
Professional record
- NPI
- 1396772943
- Licence
- KS 0423744
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 1990
- Group
- Holy Family Medical Inc · Amberwell Atchison Association
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 261QF0400X (261QF0400X)
- Mailing address
- 144 S Hillside St, Wichita, KS, 67211
- NPI first listed
- 2006-06-27
- NPI last updated
- 2026-03-11
- NPI record certified
- 2026-03-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 800 Ravenhill Dr, Atchison, KS, 66002